Following the Company’s AGM in Melbourne on November 23, 2016, Noxopharm Limited ( ASX: NOX) will be holding an AGM Sydney Briefing on November 25th at 4pm at the Grace Hotel, 77 York Street, Sydney.
Attendees will have the opportunity to meet with the Noxopharm Board of Directors.
CEO, Dr Graham Kelly, also will review the Company’s clinical trial programme and general drug development strategy.
Download this document
